NCT04619147View on ClinicalTrials.gov

Invasive Fungal Infections in Patients Following Stem Cell Transplant

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 15, 2022

Primary Completion Date

April 20, 2024

Study Completion Date

April 20, 2024

Conditions
Invasive Fungal InfectionsStem Cell Transplant Complications
Interventions
OTHER

No intervention

This is descriptive, retrospective study to evaluate the epidemiology of invasive fungal infections (IFI) in patients undergoing allogeneic haematopoiectic stem cell transplant in the era of antifungal prophylaxis with posaconazole delay-released tablets.

Trial Locations (1)

3000

Peter MacCallum Cancer Centre, Melbourne

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Peter MacCallum Cancer Centre, Australia

OTHER